- Ruth M Ayling
- Ann Bowron
Table A6.1
ANALYTE | UNIT | REFERENCE RANGE | COMMENT | ||||||
---|---|---|---|---|---|---|---|---|---|
Preterm | Term | ||||||||
Gestational age (weeks) | Age | Reference range | Age | Reference range | |||||
Alanine aminotransferase (ALT) ( ) | IU/l | M | F | Range dependent on methodology | |||||
1–7 d | 6–40 | 7–40 | |||||||
8–30 d | 10–40 | 8–32 | |||||||
Albumin ( ; ) | g/l | 27 | 21–33 | M | F | ||||
29 | 23–34 | 1–7 d | 24–39 | 19–40 | |||||
31 | 22–35 | 8–30 d | 21–45 | 19–44 | |||||
33 | 22–35 | ||||||||
35 | 22–36 | ||||||||
Alkaline phosphatase (ALP) ( ) | IU/l | M | F | Range dependent on methodology | |||||
1–7 d | 107–357 | ||||||||
8–30 d | 107–474 | ||||||||
α 1 -antitrypsin ( ) | g/l | 0–30 d | 0.79–2.23 | ‘Adult’ concentrations at birth, falling after 2 weeks. To assess possible deficiency, phenotype should be determined | |||||
α-fetoprotein (AFP) ( ) | U/ml | Birth | 7533–157 390 | Range dependent on methodology Higher in premature babies Half-life 5.1 days | |||||
1 d | 6561–137 082 | ||||||||
2 d | 5741–119 393 | ||||||||
3 d | 4977–103 988 | ||||||||
4 d | 4375–90 569 | ||||||||
5 d | 3819–79 796 | ||||||||
6 d | 3335–69 660 | ||||||||
7 d | 2911–60 811 | ||||||||
8–14 d | 1222–48 640 | ||||||||
15–21 d | 475–18 924 | ||||||||
22–28 d | 261–5212 | ||||||||
Aldosterone ( ) | ng/dL | 26–28 | 4 d | 5–635 | 3 d | 7–184 | |||
31–35 | 4 d | 19–141 | 1 w | 5–175 | |||||
1 m | 5–90 | ||||||||
Aluminium ( ) | µmol/l | 0.07–0.80 | |||||||
Ammonia ( ) | µmol/l | 0–30 d | 21–95 | Preterm and/or sick babies may have concentrations up to 200 µmol/l | |||||
Amylase ( ) | IU/l | 0–30 d | <30 | Range dependent on methodology | |||||
Androstenedione ( ) | nmol/l | M | F | ||||||
0 d | 1.47–13 | 0.8–12 | |||||||
15 d | 1.0–8.7 | 0.7–7.9 | |||||||
30 d | 0.6–5.9 | 0.5–5.3 | |||||||
Aspartate transaminase (AST) ( ) | IU/l | M | F | Range dependent on methodology | |||||
1–7 d | 26–98 | 20–93 | |||||||
8–30 d | 16–67 | 20–69 | |||||||
Bilirubin ( ) | µmol/l | Birth–1 d | <100 | Refer to neonatal treatment charts for further details | |||||
<140 | |||||||||
1–2 d | <200 | ||||||||
Total | 3–5 d | ||||||||
Conjugated | 0–30 d | <10 | |||||||
Caeruloplasmin ( ) | mg/l | M | F | Increases from birth throughout first year | |||||
1–30 d | 77–253 | 33–275 | |||||||
Calcium | mmol/l | M | F | Results should be interpreted in conjunction with serum albumin concentration | |||||
Total ( ; ) | 21–28 | 2.14–2.65 | 0–7 d | 1.83–2.85 | 1.88–2.83 | ||||
8–30 d | 2.15–2.93 | 2.10–2.98 | |||||||
1.05–1.37 | |||||||||
1.10–1.44 | |||||||||
1.20–1.48 | |||||||||
Ionised ( ; ) | mmol/l | 25–36 | 1 d | 0.81–1.41 | 1 d | ||||
2 d | 0.72–1.44 | 3 d | |||||||
3 d | 1.04–1.52 | 5 d | |||||||
Chloride ( ) | mmol/l | 0–30 d | 97–108 | ||||||
Cholesterol ( ) | mmol/l | M | F | Gradual increase from birth | |||||
1–30 d | 1.4–3.9 | 1.6–4.0 | |||||||
Copper ( ) | µmol/l | 28–34 | 3.0–8.3 | 0–5 d | 1.4–7.2 | Rapid increase during first week | |||
5–28 d | 4.0–11.0 | ||||||||
Cortisol ( ; ) | mmol/l | 24 | 0–14 d | 73–562 | 0 d | 54–839 | If there is doubt about the integrity of the hypothalamo-pituitary adrenal axis, a short Synacthen test should be performed | ||
3 d | 54–814 | ||||||||
15 d | 54–728 | ||||||||
30 d | 55–645 | ||||||||
C-reactive protein (CRP) ( ) | mg/l | <16 | |||||||
Creatine kinase (CK) ( ) | IU/l | Cord blood | 70–380 | Range dependent on methodology | |||||
5–8 h | 214–1175 | ||||||||
24–33 h | 130–1200 | ||||||||
72–100 h | 87–725 | ||||||||
Creatinine ( ; ; ) | µmol/l | 24–28 | 1 d | 35–136 | 2 d | 37–113 | Creatinine rises in the first 48 h, especially in infants <30 weeks’ gestation ( ) | ||
29–36 | 1 d | 27–175 | 7 d | 14–86 | |||||
26–34 | 1 w | 69–141 | 14 d | 18–58 | |||||
2 w | 45–99 | 21 d | 15–55 | ||||||
3–4 w | 39–71 | 28 d | 12–48 | ||||||
5–6 w | 42–62 | ||||||||
7–9 w | 39–48 | ||||||||
Cystatin C ( ) | mg/l | 24–28 | 0.65–3.37 | 0–28 d | 0.81–2.32 | ||||
29–36 | 0.62–4.42 | ||||||||
Dehydroepiandrosterone sulphate (DHEAS) ( ) | µmol/l | M | F | ||||||
0 d | 0.7–8.9 | 0.8–10 | |||||||
3 d | 0.7–8.4 | 0.9–9.6 | |||||||
15 d | 0.6–6.6 | 0.7–8.1 | |||||||
30 d | 0.5–4.8 | 0.6–6.3 | |||||||
Ferritin ( ) | µg/l | M | F | ||||||
1–30 d | 36–381 | 36–483 | |||||||
Glucose ( ) | mmol/l | 1–7 d | 2.71–6.11 | ||||||
8–30 d | 3.00–6.49 | ||||||||
γ-Glutamyltransferase (GGT) ( ) | IU/l | 1–7 d | 18–148 | Results depend on methodology | |||||
8–30 d | 16–140 | ||||||||
17α-Hydroxyprogesterone (17-OHP) ( ) | nmol/l | 0 d | 17.2–252 | Premature and/or sick infants may have concentrations 2–3-fold higher | |||||
3 d | 9.9–33.1 | ||||||||
15 d | 8.8–29.2 | ||||||||
30 d | 7.4–24.5 | ||||||||
Immunoglobulins ( ) | M | F | Lower in premature infants | ||||||
IgG | g/l | 1–30 d | 2.21–8.38 | 1.88–8.76 | |||||
IgA | g/l | 0.01–0.17 | 0.01–0.16 | ||||||
IgM | g/l | 0.08–0.78 | 0.13–0.70 | ||||||
IgD | mg/l | none detected | |||||||
IgE | kIU/l | 0–12 m | 2–24 | 0–20 | |||||
Immunoreactive trypsin ( ) | µg/l | <60 | Blood spot | ||||||
Insulin | Should be measured during documented hypoglycaemia. There may be cross-reactivity with proinsulins and values may be higher in premature infants, hence results should always be interpreted in light of clinical features and intravenous glucose requirements | ||||||||
Insulin-like growth factor-1 (IGF-1) ( ) | ng/ml | 0 d | 22.8–100.9 | ||||||
1–30 d | 7–92 | ||||||||
Insulin-like growth factor binding protein-3 (IGFBP-3) ( ) | mg/l | 0–1 w | 0.42–1.39 | ||||||
1–4 w | 0.77–2.09 | ||||||||
Iron ( ) | µmol/l | M | F | ||||||
0–30 d | 5.7–20.0 | 5.2–22.7 | |||||||
Lactate ( ) | mmol/l | 0–90 d | 1.0–3.5 | ||||||
Lactate dehydrogenase (LDH) ( ) | U/l | M | F | Results depend on methodology | |||||
1–30 d | 178–629 | 187–600 | |||||||
1–3 m | 158–373 | 152–353 | |||||||
Magnesium ( ; ) | mmol/l | 25–36 | 1 d | 0.62–1.02 | 1 d | 0.72–1.00 | |||
3 d | 0.66–1.10 | 3 d | 0.81–1.05 | ||||||
5 d | 0.68–1.24 | 5 d | 0.78–1.02 | ||||||
7–28 d | 0.75–1.00 | 7–28 d | 0.65–1.00 | ||||||
Manganese ( ) | nmol/l | >360 | Risk of toxicity | ||||||
Non-esterified fatty acids ( ) | mmol/l | 26–36 | 3 d | 0.01–1.04 | 3 d | 0.04–1.34 | |||
Osmolality ( ) | mosmol/kg | Birth | 275–300 | 275–295 | |||||
7 d | 276–305 | ||||||||
28 d | 274–305 | ||||||||
Phenylalanine ( ) | µmol/l | 98–213 | 38–137 | ||||||
Phosphate ( ) | mmol/l | 2–3 d | 1.81–3.00 | Tends to be higher in babies fed formula milk | |||||
3–4 d | 1.74–2.76 | ||||||||
4–6 d | 1.64–2.70 | ||||||||
6–12 d | 1.39–3.03 | ||||||||
21 d | 1.74–2.66 | ||||||||
Potassium ( ; ) | mmol/l | 7 d | 4.6–6.7 | 0–1 w | 3.2–5.7 | Results from capillary blood tend to be higher. Serum potassium concentrations are higher than those of plasma due to potassium released from platelets during clotting | |||
1 w–1 m | 3.4–6.2 | ||||||||
Prolactin ( ) | mU/l | 0–30 d | 9–2850 | May be considerably higher in the first 2 weeks | |||||
Protein ( ; ) (total) | g/l | 22–36 | 36–63 | 1–30 d | 41–63 | ||||
Pyruvate ( ) | µmol/l | 1–30 d | 80–150 | ||||||
Selenium ( ) | µmol/l | 0–4 w | 0.19–1.35 | ||||||
Sodium ( ) | mmol/l | 0–7 d | 131–144 | ||||||
7–31 d | 132–142 | ||||||||
Testosterone ( ) | nmol/l | M | F | M | F | ||||
26–28 | 4 d | 2.1–4.4 | 0.18–0.6 | 2.6–14 | 0.7–2.2 | ||||
31–35 | 4 d | 1.3–6.9 | 0.18–0.8 | ||||||
Thyroid-stimulating hormone (TSH) ( ; ; ) | mU/l | 28–40 | >7 d | 0.8–12.0 | 1 d | 3.0–120 | Rapid increase during the first 24 h | ||
2 d | 3.0–30 | ||||||||
3–30 d | 0.5–6.0 | ||||||||
Thyroxine ( ; ) free (FT 4 ) | pmol/l | 25–30 | 0–7 | 6.4–42.5 | 1–3 d | 25.7–68.2 | |||
31–36 | 0–7 | 16.7–60.6 | 1–4 w | ||||||
Triiodothyronine ( ; ; ) free (FT 3 ) | pmol/l | 29–36 | 1–3 d | 1.2–7.3 | 1–3 d | 2.5–9.3 | Lower in small sick infants | ||
4–10 d | 1.2–4.9 | 4–10 d | 2.8–5.7 | ||||||
Triglyceride ( ) | mmol/l | M | F | ||||||
0–7 d | 0.24–2.06 | 0.32–1.88 | |||||||
8–30 d | 0.34–2.08 | 0.34–1.86 | |||||||
Urate ( ) | µmol/l | 0–1 d | 300–505 | ||||||
1–2 d | 200–490 | ||||||||
2–3 d | 190–395 | ||||||||
3–7 d | 150–290 | ||||||||
Urea ( ) | mmol/l | 1–7 d | 0.7–4.6 | May be higher in infants fed formula milk | |||||
8–30 d | 0.7–5.7 | ||||||||
Zinc ( ; Lockitch et al. 1998) | µmol/l | 28–34 | 10–24 | 0–5 d | 9.9–21.4 | Higher in preterms. Concentration decreases during first week |